RCT
Published: Nov 2009
ACE Report #5098
Ace Report Cover Tumour

MTP-PE added to chemotherapy did not improve outcomes in metastatic osteosarcoma patients

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group

Cancer. 2009 Nov 15;115(22):5339-48. doi: 10.1002/cncr.24566

Contributing Authors: Z Chen RB Womer MD Krailo JH Healey AJ Chou ES Kleinerman DL Betcher Conrad EU ML Nieder MA Weiner RJ Wells PA Meyers Children's Oncology Group

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Explore some of our unlocked reports below!

Treatment of osteoarthritis: A role for education programmes?
The prevalence of intimate partner violence in women presenting to orthopaedic clinics
Osteoporosis Choice decision aid improves treatment experience of clinicians and patients
Protein-Rich nutritional supplementation shows limited efficacy in elderly hip fractures
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.